(Q38088776)

28 August 2017

title

Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis (English)

1 reference

28 August 2017

1 reference

Sushmita Chakraborty

1

1 reference

ORCID Public Data File 2021

author name string

Puneet Chopra

2

1 reference

28 August 2017

Anushree Hak

3

1 reference

28 August 2017

Sunanda Ghosh Dastidar

4

1 reference

28 August 2017

Abhijit Ray

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

Expert Opinion on Investigational Drugs

28 August 2017

published in

1 reference

28 August 2017

volume

22

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

499-515

1 reference

Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Mechanisms of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Response of the lower respiratory tract to injury. Mechanisms of repair of the parenchymal cells of the alveolar wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Incidence and prevalence of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Epithelial/mesenchymal interactions and branching morphogenesis of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

21 January 2018

Cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Myofibroblasts and mechano-regulation of connective tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Transformation of alveolar Type 2 cells to Type 1 cells following exposure to NO2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Apoptosis in lung fibrosis and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Wound repair and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

The myofibroblast in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Bone marrow-derived progenitor cells in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Evolving concepts of apoptosis in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Resistance to Fas-mediated apoptosis in human lung fibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Current and future treatment options in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Activation of the JNK pathway is essential for transformation by the Met oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

An overview of the c-MET signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Cell-specific expression of human HGF by alveolar type II cells induces remodeling of septal wall tissue in the lung: a morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Targeted gene transfer of hepatocyte growth factor to alveolar type II epithelial cells reduces lung fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-alpha or oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatic growth factor (HGF) inhibits cigarette smoke extract induced apoptosis in human bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor regulates angiotensin converting enzyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Lung cancer in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778972

Cell Death in Development

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)80564-4

Identifiers

DOI

10.1517/13543784.2013.778972

1 reference

28 August 2017

1 reference